Drug Shortage Report for GABAPENTIN TABLETS USP
| Report ID | 191750 |
| Drug Identification Number | 02392526 |
| Brand name | GABAPENTIN TABLETS USP |
| Common or Proper name | GABAPENTIN TABLETS USP |
| Company Name | ACCORD HEALTHCARE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 600MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N02BF |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-05-05 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-10-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-10-04 | French | Compare |
| v4 | 2023-10-04 | English | Compare |
| v3 | 2023-05-06 | English | Compare |
| v2 | 2023-05-05 | French | Compare |
| v1 | 2023-05-05 | English | Compare |
Showing 1 to 5 of 5